Line, John Eric and Seal, Bruce S. and Garrish, Johnna K. (2022) Selected Antimicrobial Peptides Inhibit In Vitro Growth of Campylobacter spp. Applied Microbiology, 2 (4). pp. 688-700. ISSN 2673-8007
applmicrobiol-02-00053.pdf - Published Version
Download (812kB)
Abstract
Campylobacter is a major cause of acute human diarrheal illness. Broiler chickens constitute a primary reservoir for C. jejuni leading to human infection. Consequently, there is a need for developing novel intervention methods. Antimicrobial peptides (AMP) are small proteins which have evolved in most lifeforms to provide defense against microbial infections. To date, over 3000 AMP have been discovered; however, few of them have been analyzed specifically for ability to kill campylobacters. We selected and evaluated a set of 11 unique chemically synthesized AMP for ability to inhibit growth of C. jejuni. Six of the AMP we tested produced zones of inhibition on lawns of C. jejuni. These AMP included: NRC-13, RL-37, Temporin L, Cecropin–Magainin, Dermaseptin, and C12K-2β12. In addition, MIC were determined for Cecropin–Magainin, RL-37 and C12K-2β12 against 15 isolates of Campylobacter representing the three most common pathogenic strains. MIC for campylobacters were approximately 3.1 µg/mL for AMP RL-37 and C12K-2β12. MIC were slightly higher for the Cecropin–Magainin AMP in the range of 12.5 to 100 µg/mL. These AMP are attractive subjects for future study and potential in vivo delivery to poultry to reduce Campylobacter spp. populations.
Item Type: | Article |
---|---|
Subjects: | Library Eprints > Biological Science |
Depositing User: | Managing Editor |
Date Deposited: | 29 Nov 2022 04:54 |
Last Modified: | 29 Jul 2024 05:44 |
URI: | http://news.pacificarchive.com/id/eprint/517 |